Stay updated on Daratumumab Combo in Resistant Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in Resistant Myeloma Clinical Trial page
- Check5 days agoChange DetectedNo additions or deletions are listed in the data, so there is no textual change to evaluate. The page content remains as previously captured, continuing to present the study's details about Daratumumab + Dexamethasone in resistant or refractory multiple myeloma.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3; this indicates an update to the page's underlying software/version label rather than a change to the study content.SummaryDifference0.0%

- Check19 days agoChange DetectedThe disease keyword 'Multiple myeloma' and the related topics section including MedlinePlus Genetics have been removed. This changes how the study is categorized on the page and eliminates a direct link to related resources.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, indicating a small backend/template update for the page. The study details themselves remain unchanged.SummaryDifference0.0%

- Check41 days agoChange DetectedSite revision updated to v3.5.2; removed the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related topics, and the previous 'Revision: v3.5.0' note.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded a Publications section containing the final results of IFM2014-04 (Daratumumab + Dexamethasone) with DOI 10.1111/bjh.16059 and related note; updated Study Results with the 2026-04-01 entry.SummaryDifference0.3%

Stay in the know with updates to Daratumumab Combo in Resistant Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.